Filana Therapeutics (FLNA) Capital Expenditures (2011 - 2025)
Filana Therapeutics (FLNA) posted quarterly Capital Expenditures of $501000.0 for Q4 2025, up 778.95% year-over-year from $57000.0 in Q4 2024, and up 526.25% quarter-over-quarter from $80000.0 in Q3 2025.
Filana Therapeutics (FLNA) Capital Expenditures (2011 - 2025) Analysis & Trends
Filana Therapeutics' Capital Expenditures history runs 11 years deep, the most recent figure standing at $501000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 778.95% year-over-year to $501000.0; the TTM figure through Dec 2025 stood at $581000.0 (up 464.08% YoY), while the FY2025 annual figure was $581000.0, up 464.08% from the prior year.
- Capital Expenditures for Q4 2025 stood at $501000.0, up from $80000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $22.0 million in Q3 2021, with the low at -$335000.0 in Q4 2022.
- The 5-year median for Capital Expenditures is $80000.0 (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 435.0% in 2022, then soared 778.95% in 2025.
- Filana Therapeutics' Capital Expenditures stood at $100000.0 in 2021, then slumped by 435.0% to -$335000.0 in 2022, then jumped by 112.24% to $41000.0 in 2023, then soared by 39.02% to $57000.0 in 2024, then jumped by 778.95% to $501000.0 in 2025.
- Business Quant data shows FLNA's Capital Expenditures at $501000.0 in Q4 2025, $80000.0 in Q3 2025, and $57000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | Filana Therapeutics | 45.29 Mn | 45.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 501,000.00 |
| Dec 31, 2025 | 501,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | -335,000.00 |
| Dec 31, 2022 | -335,000.00 |